Ivan Astralaga
Corporate Officer/Principal chez C-RAD AB
Fortune : 72 618 $ au 30/04/2024
Postes actifs de Ivan Astralaga
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| C-RAD AB | Corporate Officer/Principal | 21/05/2021 | - |
Historique de carrière de Ivan Astralaga
Anciens postes connus de Ivan Astralaga
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Mevion Medical Systems, Inc.
 Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Sales & Marketing | 01/08/2019 | 01/04/2021 |
Statistiques
Internationale
| Suède | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| C-RAD AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Health Technology |
- Bourse
- Insiders
- Ivan Astralaga
- Expérience
